Quick Answer
BIOXYTRAN, INC reported Gross Profit of $87.1 thousand for the year ending 2017.
- BIOXYTRAN, INC showed a decrease of -42.0% in Gross Profit from 2016 to 2017.
- This data is from BIOXYTRAN, INC's annual report (Form 10-K), filed with the SEC on April 2, 2018.
- XBRL data for this metric is available from 2010 to 2017 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $4.9 thousand | Q3 2010: $1.3 thousand | Q1 2011: $5.9 thousand | Q2 2011: $24.1 thousand | Q3 2011: $9.9 thousand | Q1 2012: $98.7 thousand | Q2 2012: $81.2 thousand | Q3 2012: -$35.5 thousand | Q1 2013: $103.9 thousand | Q2 2013: $55.3 thousand | Q3 2013: $14.5 thousand | Q1 2014: $154.2 thousand | Q2 2014: $25.8 thousand | Q3 2014: $7.2 thousand | Q1 2015: $47.9 thousand | Q2 2015: $44.7 thousand | Q3 2015: $43.0 thousand | Q1 2016: $14.7 thousand | Q2 2016: $36.8 thousand | Q3 2016: $62.9 thousand | Q1 2017: -$6.2 thousand | Q2 2017: $20.1 thousand | Q3 2017: $80.1 thousand | Q1 2018: -$1.9 thousand | Q2 2018: $12.2 thousand.
- Over the full 8 years of available data (2010 to 2017), BIOXYTRAN, INC's Gross Profit has grown by 619.9%.
- Historical annual values: Fiscal year 2017: $87.1 thousand | Fiscal year 2016: $150.2 thousand | Fiscal year 2015: $120.1 thousand | Fiscal year 2014: $109.6 thousand | Fiscal year 2013: $219.9 thousand | Fiscal year 2012: $191.0 thousand | Fiscal year 2011: $57.2 thousand | Fiscal year 2010: $12.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: